SOLV Solventum Corporation

84.50USD-1.52%Mkt Cap: 14.36B USDP/E: 94.94

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates throug…

Institutional holders20 on file

Key Statistics

Company
Market Cap14.36B USD
Enterprise Value19.41B USD
Revenue (TTM)8.16B USD
Gross Profit4.45B USD
Net Income (TTM)1.56B USD
Revenue/Share47.17 USD
Last Price84.50 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees20.6K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)94.94
P/E (Forward)11.20
PEG1.22
EV/EBITDA19.35
EV/Revenue2.38
P/S1.76
P/B2.99
EPS (TTM)0.89 USD
EPS (Forward)7.54 USD
52W Range
62.3870% of range94.16
52W High94.16 USD
52W Low62.38 USD
Profitability
Gross Margin53.47%
Oper. Margin5.91%
EBITDA Margin12.29%
Profit Margin18.69%
ROE30.81%
ROA10.89%
ROIC6.24%
ROCE5.66%
Growth
Revenue Growth-7.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF369.00M USD
CapEx (TTM)379.00M USD
FCF Margin2.21%
FCF Yield1.25%
Net Debt4.84B USD
Net Debt/EBITDA4.83
Net Debt/FCF26.89
Balance Sheet
Debt/Equity1.00
Current Ratio1.03
Quick Ratio0.52
Book Value/Sh28.27 USD
Cash/Share2.66 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)98.38 USD
Upside (mean)+16.4%
Target Range75.00 USD – 115.00 USD
75.00+16.4% to mean115.00
# Analysts13
Ownership
Shares Out.169.96M
Float143.56M
Insiders15.37%
Institutions77.15%
Short Interest
Short Ratio4.8d
Short % Float3.50%
Short % Out.2.97%
Shares Short5.05M
Short (prev mo.)4.89M
Technical
SMA 5087.30 (-3.2%)
SMA 20079.00 (+7.0%)
Beta0.75
S&P 52W Chg12.00%
Avg Vol (30d)1.14M
Avg Vol (10d)1.26M
Technical Indicators
RSI (14)42.3
MACD-0.0665
MACD Signal0.2192
MACD Hist.-0.2857
BB Upper92.21 USD
BB Middle86.52 USD
BB Lower80.84 USD
BB Width13.15%
ATR (14)2.654 USD
Vol Ratio (20d)0.50x

About Solventum (NYSE: SOLV)

›

Solventum (NYSE: SOLV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 20,584 employees.

The shares were at 84.50 USD on 20 November 2026, up 10.9% over 52 weeks. Its 52-week range is 62.38 USD to 94.16 USD: the price is 10.3% below the high and 35.5% above the low.

At a market capitalisation of 14.36B USD, it trades at 94.9 times trailing earnings and 11.2 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 47.2, a premium of 101% for SOLV.

Solventum reports return on equity of 30.8%, an operating margin of 5.9% and revenue down 7.0% year over year.

Its debt exceeds its cash by 4.84B USD, a debt-to-equity ratio of 1.00. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 13 analysts cover the stock, with an average rating of Buy; their mean price target of 98.38 USD is 16.4% above the current price. The next earnings report is expected on 25 February 2027.